SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UPDATE: Sarepta Reports StrideBio Will Be Responsible For AAV Capsid Development, Non-Clinical Development, Manufacturing Of Preclinical Candidates To Be Selected For Advancement Into Clinical Studies

Benzinga · -